tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MYGN Stock Latest News

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk
Press ReleasesWhat We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk
10h ago
MYGN
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
PremiumPress Releases
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
6d ago
MYGN
Myriad Genetics, Personalis enter agreement to cross-license patent estates
PremiumThe Fly
Myriad Genetics, Personalis enter agreement to cross-license patent estates
6d ago
MYGN
PSNL
Myriad Genetics announces second foundational patent granted for MRD
PremiumThe Fly
Myriad Genetics announces second foundational patent granted for MRD
8d ago
MYGN
Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
PremiumPress Releases
Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
8d ago
MYGN
Myriad Genetics Earns 2024 Great Place To Work® Certification™
PremiumPress ReleasesMyriad Genetics Earns 2024 Great Place To Work® Certification™
15d ago
MYGN
Scotiabank starts Myriad Genetics with Outperform amid transformation
PremiumThe Fly
Scotiabank starts Myriad Genetics with Outperform amid transformation
20d ago
MYGN
Myriad Genetics initiated with an Outperform at Scotiabank
PremiumThe Fly
Myriad Genetics initiated with an Outperform at Scotiabank
21d ago
MYGN
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
PremiumPress Releases
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
23d ago
MYGN
Myriad Genetics announces collaboration with GSK
PremiumThe Fly
Myriad Genetics announces collaboration with GSK
1M ago
GSK
MYGN
Myriad Genetics launches new Universal Plus Panel for Foresight Carrier Screen
PremiumThe Fly
Myriad Genetics launches new Universal Plus Panel for Foresight Carrier Screen
1M ago
MYGN
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
PremiumPress Releases
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
1M ago
MYGN
Myriad Genetics Proposes Settlement in Shareholder Lawsuits
PremiumCompany AnnouncementsMyriad Genetics Proposes Settlement in Shareholder Lawsuits
1M ago
8K
MYGN
Myriad Genetics announces RiskScore study results published
PremiumThe Fly
Myriad Genetics announces RiskScore study results published
1M ago
MYGN
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
PremiumPress Releases
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
1M ago
MYGN
Best Buy upgraded, Target initiated: Wall Street’s top analyst calls
PremiumThe Fly
Best Buy upgraded, Target initiated: Wall Street’s top analyst calls
1M ago
BBY
KMB
Myriad Genetics assumed with Underperform from Hold at Jefferies
PremiumThe Fly
Myriad Genetics assumed with Underperform from Hold at Jefferies
1M ago
MYGN
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
PremiumPress Releases
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
2M ago
MYGN
Myriad Genetics and Qiagen to co-develop HRD test
PremiumThe Fly
Myriad Genetics and Qiagen to co-develop HRD test
2M ago
MYGN
QGEN
Qiagen, Myriad Genetics to develop kit-based test for analyzing HRD status
PremiumThe FlyQiagen, Myriad Genetics to develop kit-based test for analyzing HRD status
2M ago
MYGN
QGEN
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
PremiumPress Releases
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
2M ago
MYGN
New Study Published in JCO Precision Oncology Shows Myriad Genetics’ Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
PremiumPress Releases
New Study Published in JCO Precision Oncology Shows Myriad Genetics’ Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
2M ago
MYGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >